Mansoureh Eghbali Selected Research

phospholipid emulsion soybean oil (Intralipid)

1/2018	Free Fatty Acid Receptor G-protein-coupled Receptor 40 Mediates Lipid Emulsion-induced Cardioprotection.
1/2017	Intralipid protects the heart in late pregnancy against ischemia/reperfusion injury via Caveolin2/STAT3/GSK-3β pathway.
8/2015	Involvement of Opioid Receptors in the Lipid Rescue of Bupivacaine-Induced Cardiotoxicity.
10/2012	Intralipid, a clinically safe compound, protects the heart against ischemia-reperfusion injury more efficiently than cyclosporine-A.
9/2011	Intralipid prevents and rescues fatal pulmonary arterial hypertension and right ventricular failure in rats.
8/2011	Phosphorylation of GSK-3β mediates intralipid-induced cardioprotection against ischemia/reperfusion injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mansoureh Eghbali Research Topics

Disease

13	Pulmonary Hypertension 01/2022 - 09/2011
8	Pulmonary Arterial Hypertension 01/2021 - 09/2011
7	Fibrosis (Cirrhosis) 01/2020 - 09/2011
7	Hypertrophy 01/2017 - 06/2005
6	Vascular Remodeling 01/2020 - 07/2012
6	Reperfusion Injury 01/2019 - 01/2010
5	Cardiomegaly (Heart Hypertrophy) 01/2016 - 06/2005
4	Cardiovascular Diseases (Cardiovascular Disease) 06/2020 - 02/2014
4	Infarction (Infarctions) 01/2019 - 01/2010
4	Ischemia 01/2018 - 01/2010
3	Hypoxia (Hypoxemia) 01/2022 - 08/2014
3	Right Ventricular Hypertrophy 01/2020 - 08/2012
3	Heart Failure 10/2018 - 08/2012
3	Cardiotoxicity 01/2018 - 08/2012
3	Inflammation (Inflammations) 01/2016 - 09/2011
2	Neoplasms (Cancer) 01/2022 - 03/2009
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 06/2021 - 11/2020
2	Atherosclerosis 01/2020 - 01/2017
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2019 - 01/2017
2	Myocardial Infarction 01/2017 - 10/2012
2	Vascular Diseases (Vascular Disease) 12/2015 - 08/2014
2	Heart Arrest (Cardiac Arrest) 08/2015 - 08/2012
1	Sepsis (Septicemia) 11/2020
1	Radiation Injuries (Radiation Sickness) 01/2020
1	Right Ventricular Dysfunction 01/2020
1	Left Ventricular Dysfunction 01/2020
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2019
1	Ganglion Cysts (Ganglion) 12/2017
1	Cicatrix (Scar) 01/2016
1	Coronary Disease (Coronary Heart Disease) 06/2014

Drug/Important Bio-Agent (IBA)

11	Estrogens (Estrogen)FDA Link 10/2019 - 06/2005
8	LipidsIBA 01/2020 - 08/2012
6	MicroRNAs (MicroRNA)IBA 06/2021 - 01/2012
6	Estrogen ReceptorsIBA 06/2020 - 01/2010
6	phospholipid emulsion soybean oil (Intralipid)IBA 01/2018 - 08/2011
5	Proteins (Proteins, Gene)FDA Link 10/2019 - 03/2009
4	Peptides (Polypeptides)IBA 01/2020 - 03/2009
4	CalciumIBA 01/2019 - 08/2012
3	MonocrotalineIBA 01/2021 - 08/2014
3	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2020 - 08/2014
3	Bupivacaine (Bupivacaine Hydrochloride)FDA LinkGeneric 01/2018 - 08/2012
3	EmulsionsIBA 01/2018 - 08/2012
3	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2017 - 01/2012
2	Biomarkers (Surrogate Marker)IBA 06/2021 - 01/2016
2	AcidsIBA 01/2020 - 08/2014
2	GenisteinIBA 12/2015 - 08/2012
2	EnzymesIBA 10/2012 - 07/2012
2	Glycogen Synthase (Synthase I)IBA 10/2012 - 08/2011
2	Mitochondrial Permeability Transition PoreIBA 10/2012 - 08/2011
2	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 10/2012 - 08/2011
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2012 - 03/2009
2	phospholambanIBA 11/2006 - 06/2005
2	Atrial Natriuretic Factor (ANF)IBA 11/2006 - 06/2005
1	Small Interfering RNA (siRNA)IBA 01/2022
1	ChemokinesIBA 01/2022
1	Messenger RNA (mRNA)IBA 06/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	15-hydroxy-5,8,11,13-eicosatetraenoic acidIBA 01/2020
1	phenylpiperazineIBA 01/2020
1	oxidized low density lipoproteinIBA 01/2020
1	LDL Receptors (LDL Receptor)IBA 01/2020
1	Aryldialkylphosphatase (Paraoxonase)IBA 01/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019
1	NAD (NADH)IBA 10/2018
1	Estrogen Receptor betaIBA 10/2018
1	GW1100IBA 01/2018
1	Nonesterified Fatty Acids (NEFA)IBA 01/2018
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2018
1	Adrenergic Receptors (Adrenergic Receptor)IBA 12/2017
1	Prostaglandins IIBA 08/2017
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2017
1	Endothelins (Endothelin)IBA 08/2017
1	Biological FactorsIBA 01/2017
1	Apolipoproteins E (ApoE)IBA 01/2017
1	ApolipoproteinsIBA 01/2017
1	AndrogensIBA 01/2017
1	Gonadal HormonesIBA 01/2017
1	Aromatase (CYP19)IBA 01/2016
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2015
1	HDL LipoproteinsIBA 12/2015
1	Oxidants (Oxidizing Agents)IBA 12/2015
1	BuffersIBA 08/2015
1	Naloxone (Narcan)FDA LinkGeneric 08/2015
1	Narcotic Antagonists (Opioid Antagonists)IBA 08/2015
1	Phosphates (Orthophosphate)IBA 08/2015
1	Opioid Receptors (Opioid Receptor)IBA 08/2015
1	SolutionsIBA 08/2015
1	Local AnestheticsIBA 08/2015
1	N-methylnaloxoneIBA 08/2015
1	Insulin (Novolin)FDA Link 08/2014
1	LipoxygenasesIBA 08/2014
1	apolipoprotein A-I mimetic peptide 4FIBA 08/2014
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2012
1	Superoxides (Superoxide)IBA 10/2012

Therapy/Procedure

12	Therapeutics 11/2020 - 09/2011
2	Radiotherapy 01/2022 - 03/2009
1	Denervation 12/2017
1	Estrogen Replacement Therapy 01/2017
1	Resuscitation 08/2015